Report Detail
Global (United States, European Union and China) C-MET / HGF Inhibitors Market Research Report 2019-2025
- RnM3715645 |
- 02 September, 2019 |
- Global |
- 140 Pages |
- QYResearch |
- Pharma & Healthcare
c-Met is a proto-oncogene responsible for encoding the high-affinity receptor for hepatocyte growth factor (HGF). Hepatocyte growth factor is also known as scatter factor which participates in HGF/c-MET signaling pathway. This pathway plays vital role in mitogenesis and morphogenesis during embryonic development and wound healing. The controlled natural activity of c-Met and HGF is important in mammalian development, tissue maintenance, and repair. Binding of HGF to c-MET receptor induces several biological responses collectively known as invasive growth program. These responses are elicited due to activation of several pathways such as RAS pathway, PI3K pathway, STAT pathway, beta-catenin pathway and Notch pathway. However, dysregulation of the HGF/c-MET signaling pathway has been associated with the progression of cancers through activation of oncogenic pathways, angiogenesis and metastasis.
The major cancers such as breast, colon and non-small-cell lung carcinoma (NSCLC) are being examined for efficacy with c-MET / HGF inhibitors. Several small molecule c-Met kinase inhibitors have demonstrated clinical efficacy in cancer treatment and many clinical trials are underway. However, as the small molecule inhibitors lack specificity or selectivity they can cause toxicity. Therefore, researchers are increasing focus to develop antibody therapeutics against c-Met or HGF.
In 2019, the market size of C-MET / HGF Inhibitors is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for C-MET / HGF Inhibitors.
This report studies the global market size of C-MET / HGF Inhibitors, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the C-MET / HGF Inhibitors sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Abxign
Abbott Laboratories
Amgen
ArQule
Astex Therapeutics
AVEO Pharmaceuticals
Bristol-Myers Squibb(BMS)
Chroma Therapeutics
Daiichi Sankyo
Deciphera Pharmaceuticals
Eisai
Eli Lilly
Exelixis
Genmab
Galaxy Biotech
GlaxoSmithKline(GSK)
Hutchison MediPharma
Johnson & Johnson
Kringle Pharmaceuticals
Merck
Methylgene
Novartis
Pfizer
ProMetic BioTherapeutics
Takeda Pharmaceutical
Market Segment by Product Type
C-Met Biologic Inhibitors
Small Molecule C-Met Inhibitors
HGF Antagonist Antibodies
C-Met Antagonist Antibodies(MetMAb)
HGF Kringle Variant Antagonists
Market Segment by Application
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Sales
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the C-MET / HGF Inhibitors status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key C-MET / HGF Inhibitors manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of C-MET / HGF Inhibitors are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global C-MET / HGF Inhibitors Market Size Growth Rate by Type (2019-2025)
- 1.3.2 C-Met Biologic Inhibitors
- 1.3.3 Small Molecule C-Met Inhibitors
- 1.3.4 HGF Antagonist Antibodies
- 1.3.5 C-Met Antagonist Antibodies(MetMAb)
- 1.3.6 HGF Kringle Variant Antagonists
- 1.4 Market Segment by Application
- 1.4.1 Global C-MET / HGF Inhibitors Market Share by Application (2019-2025)
- 1.4.2 Hospital Pharmacies
- 1.4.3 Retail Pharmacies
- 1.4.4 Drug Stores
- 1.4.5 Online Sales
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global C-MET / HGF Inhibitors Market Size
- 2.1.1 Global C-MET / HGF Inhibitors Revenue 2014-2025
- 2.1.2 Global C-MET / HGF Inhibitors Sales 2014-2025
- 2.2 C-MET / HGF Inhibitors Growth Rate by Regions
- 2.2.1 Global C-MET / HGF Inhibitors Sales by Regions 2014-2019
- 2.2.2 Global C-MET / HGF Inhibitors Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 C-MET / HGF Inhibitors Sales by Manufacturers
- 3.1.1 C-MET / HGF Inhibitors Sales by Manufacturers 2014-2019
- 3.1.2 C-MET / HGF Inhibitors Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 C-MET / HGF Inhibitors Revenue by Manufacturers (2014-2019)
- 3.2.2 C-MET / HGF Inhibitors Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global C-MET / HGF Inhibitors Market Concentration Ratio (CR5 and HHI)
- 3.3 C-MET / HGF Inhibitors Price by Manufacturers
- 3.4 Key Manufacturers C-MET / HGF Inhibitors Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into C-MET / HGF Inhibitors Market
- 3.6 Key Manufacturers C-MET / HGF Inhibitors Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 C-Met Biologic Inhibitors Sales and Revenue (2014-2019)
- 4.1.2 Small Molecule C-Met Inhibitors Sales and Revenue (2014-2019)
- 4.1.3 HGF Antagonist Antibodies Sales and Revenue (2014-2019)
- 4.1.4 C-Met Antagonist Antibodies(MetMAb) Sales and Revenue (2014-2019)
- 4.1.5 HGF Kringle Variant Antagonists Sales and Revenue (2014-2019)
- 4.2 Global C-MET / HGF Inhibitors Sales Market Share by Type
- 4.3 Global C-MET / HGF Inhibitors Revenue Market Share by Type
- 4.4 C-MET / HGF Inhibitors Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global C-MET / HGF Inhibitors Sales by Application
6 United States
- 6.1 United States C-MET / HGF Inhibitors Breakdown Data by Company
- 6.2 United States C-MET / HGF Inhibitors Breakdown Data by Type
- 6.3 United States C-MET / HGF Inhibitors Breakdown Data by Application
7 European Union
- 7.1 European Union C-MET / HGF Inhibitors Breakdown Data by Company
- 7.2 European Union C-MET / HGF Inhibitors Breakdown Data by Type
- 7.3 European Union C-MET / HGF Inhibitors Breakdown Data by Application
8 China
- 8.1 China C-MET / HGF Inhibitors Breakdown Data by Company
- 8.2 China C-MET / HGF Inhibitors Breakdown Data by Type
- 8.3 China C-MET / HGF Inhibitors Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World C-MET / HGF Inhibitors Breakdown Data by Company
- 9.2 Rest of World C-MET / HGF Inhibitors Breakdown Data by Type
- 9.3 Rest of World C-MET / HGF Inhibitors Breakdown Data by Application
- 9.4 Rest of World C-MET / HGF Inhibitors Breakdown Data by Countries
- 9.4.1 Rest of World C-MET / HGF Inhibitors Sales by Countries
- 9.4.2 Rest of World C-MET / HGF Inhibitors Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Abxign
- 10.1.1 Abxign Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of C-MET / HGF Inhibitors
- 10.1.4 C-MET / HGF Inhibitors Product Introduction
- 10.1.5 Abxign Recent Development
- 10.2 Abbott Laboratories
- 10.2.1 Abbott Laboratories Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of C-MET / HGF Inhibitors
- 10.2.4 C-MET / HGF Inhibitors Product Introduction
- 10.2.5 Abbott Laboratories Recent Development
- 10.3 Amgen
- 10.3.1 Amgen Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of C-MET / HGF Inhibitors
- 10.3.4 C-MET / HGF Inhibitors Product Introduction
- 10.3.5 Amgen Recent Development
- 10.4 ArQule
- 10.4.1 ArQule Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of C-MET / HGF Inhibitors
- 10.4.4 C-MET / HGF Inhibitors Product Introduction
- 10.4.5 ArQule Recent Development
- 10.5 Astex Therapeutics
- 10.5.1 Astex Therapeutics Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of C-MET / HGF Inhibitors
- 10.5.4 C-MET / HGF Inhibitors Product Introduction
- 10.5.5 Astex Therapeutics Recent Development
- 10.6 AVEO Pharmaceuticals
- 10.6.1 AVEO Pharmaceuticals Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of C-MET / HGF Inhibitors
- 10.6.4 C-MET / HGF Inhibitors Product Introduction
- 10.6.5 AVEO Pharmaceuticals Recent Development
- 10.7 Bristol-Myers Squibb(BMS)
- 10.7.1 Bristol-Myers Squibb(BMS) Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of C-MET / HGF Inhibitors
- 10.7.4 C-MET / HGF Inhibitors Product Introduction
- 10.7.5 Bristol-Myers Squibb(BMS) Recent Development
- 10.8 Chroma Therapeutics
- 10.8.1 Chroma Therapeutics Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of C-MET / HGF Inhibitors
- 10.8.4 C-MET / HGF Inhibitors Product Introduction
- 10.8.5 Chroma Therapeutics Recent Development
- 10.9 Daiichi Sankyo
- 10.9.1 Daiichi Sankyo Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of C-MET / HGF Inhibitors
- 10.9.4 C-MET / HGF Inhibitors Product Introduction
- 10.9.5 Daiichi Sankyo Recent Development
- 10.10 Deciphera Pharmaceuticals
- 10.10.1 Deciphera Pharmaceuticals Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of C-MET / HGF Inhibitors
- 10.10.4 C-MET / HGF Inhibitors Product Introduction
- 10.10.5 Deciphera Pharmaceuticals Recent Development
- 10.11 Eisai
- 10.12 Eli Lilly
- 10.13 Exelixis
- 10.14 Genmab
- 10.15 Galaxy Biotech
- 10.16 GlaxoSmithKline(GSK)
- 10.17 Hutchison MediPharma
- 10.18 Johnson & Johnson
- 10.19 Kringle Pharmaceuticals
- 10.20 Merck
- 10.21 Methylgene
- 10.22 Novartis
- 10.23 Pfizer
- 10.24 ProMetic BioTherapeutics
- 10.25 Takeda Pharmaceutical
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 C-MET / HGF Inhibitors Sales Channels
- 11.2.2 C-MET / HGF Inhibitors Distributors
- 11.3 C-MET / HGF Inhibitors Customers
12 Market Forecast
- 12.1 Global C-MET / HGF Inhibitors Sales and Revenue Forecast 2019-2025
- 12.2 Global C-MET / HGF Inhibitors Sales Forecast by Type
- 12.3 Global C-MET / HGF Inhibitors Sales Forecast by Application
- 12.4 C-MET / HGF Inhibitors Forecast by Regions
- 12.4.1 Global C-MET / HGF Inhibitors Sales Forecast by Regions 2019-2025
- 12.4.2 Global C-MET / HGF Inhibitors Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on C-MET / HGF Inhibitors. Industry analysis & Market Report on C-MET / HGF Inhibitors is a syndicated market report, published as Global (United States, European Union and China) C-MET / HGF Inhibitors Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of C-MET / HGF Inhibitors market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
